Identifying Factors Associated with Low-Adherence and Subsequent HIV Seroconversions Among South African Women Enrolled in a Biomedical Intervention Trial.
Identifieur interne : 003888 ( Ncbi/Merge ); précédent : 003887; suivant : 003889Identifying Factors Associated with Low-Adherence and Subsequent HIV Seroconversions Among South African Women Enrolled in a Biomedical Intervention Trial.
Auteurs : Handan Wand [Australie] ; Gita Ramjee [Afrique du Sud]Source :
- AIDS and behavior [ 1573-3254 ] ; 2017.
Abstract
Sub-Saharan Africa has the highest number of HIV infected individuals in the world. Developing and implementing effective biomedical interventions still remains urgent. Poor adherence has been commonly identified as one of the major barriers for the success of HIV prevention trials. A better understanding of how to improve adherence remains a research priority. In this analysis, younger age (<35 years), number of children ≤2, being single/not cohabiting and having a new partner during the study follow up were all significantly associated with poor adherence and subsequent HIV seroconversions. At population level, these three factors collectively associated with 56 % of the low level adherence and 75 % of the HIV seroconversions. Results highlighted the importance of effective adherence and comprehensive contraceptive counselling of women who enrol in HIV prevention trials. Culturally and socially appropriate methods are needed to achieve and maintain optimum adherence levels in future HIV prevention research.
DOI: 10.1007/s10461-016-1471-1
PubMed: 27406228
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000963
- to stream PubMed, to step Curation: 000963
- to stream PubMed, to step Checkpoint: 000963
Links to Exploration step
pubmed:27406228Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identifying Factors Associated with Low-Adherence and Subsequent HIV Seroconversions Among South African Women Enrolled in a Biomedical Intervention Trial.</title><author><name sortKey="Wand, Handan" sort="Wand, Handan" uniqKey="Wand H" first="Handan" last="Wand">Handan Wand</name><affiliation wicri:level="3"><nlm:affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia. hwand@kirby.unsw.edu.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The Kirby Institute, University of New South Wales, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Ramjee, Gita" sort="Ramjee, Gita" uniqKey="Ramjee G" first="Gita" last="Ramjee">Gita Ramjee</name><affiliation wicri:level="1"><nlm:affiliation>HIV Prevention Research Unit, Medical Research Council, Durban, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>HIV Prevention Research Unit, Medical Research Council, Durban</wicri:regionArea><wicri:noRegion>Durban</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27406228</idno><idno type="pmid">27406228</idno><idno type="doi">10.1007/s10461-016-1471-1</idno><idno type="wicri:Area/PubMed/Corpus">000963</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000963</idno><idno type="wicri:Area/PubMed/Curation">000963</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000963</idno><idno type="wicri:Area/PubMed/Checkpoint">000963</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000963</idno><idno type="wicri:Area/Ncbi/Merge">003888</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Identifying Factors Associated with Low-Adherence and Subsequent HIV Seroconversions Among South African Women Enrolled in a Biomedical Intervention Trial.</title><author><name sortKey="Wand, Handan" sort="Wand, Handan" uniqKey="Wand H" first="Handan" last="Wand">Handan Wand</name><affiliation wicri:level="3"><nlm:affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia. hwand@kirby.unsw.edu.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The Kirby Institute, University of New South Wales, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Ramjee, Gita" sort="Ramjee, Gita" uniqKey="Ramjee G" first="Gita" last="Ramjee">Gita Ramjee</name><affiliation wicri:level="1"><nlm:affiliation>HIV Prevention Research Unit, Medical Research Council, Durban, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>HIV Prevention Research Unit, Medical Research Council, Durban</wicri:regionArea><wicri:noRegion>Durban</wicri:noRegion></affiliation></author></analytic><series><title level="j">AIDS and behavior</title><idno type="eISSN">1573-3254</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Sub-Saharan Africa has the highest number of HIV infected individuals in the world. Developing and implementing effective biomedical interventions still remains urgent. Poor adherence has been commonly identified as one of the major barriers for the success of HIV prevention trials. A better understanding of how to improve adherence remains a research priority. In this analysis, younger age (<35 years), number of children ≤2, being single/not cohabiting and having a new partner during the study follow up were all significantly associated with poor adherence and subsequent HIV seroconversions. At population level, these three factors collectively associated with 56 % of the low level adherence and 75 % of the HIV seroconversions. Results highlighted the importance of effective adherence and comprehensive contraceptive counselling of women who enrol in HIV prevention trials. Culturally and socially appropriate methods are needed to achieve and maintain optimum adherence levels in future HIV prevention research.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">27406228</PMID><DateCreated><Year>2016</Year><Month>07</Month><Day>13</Day></DateCreated><DateRevised><Year>2017</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-3254</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Feb</Month></PubDate></JournalIssue><Title>AIDS and behavior</Title><ISOAbbreviation>AIDS Behav</ISOAbbreviation></Journal><ArticleTitle>Identifying Factors Associated with Low-Adherence and Subsequent HIV Seroconversions Among South African Women Enrolled in a Biomedical Intervention Trial.</ArticleTitle><Pagination><MedlinePgn>393-401</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10461-016-1471-1</ELocationID><Abstract><AbstractText>Sub-Saharan Africa has the highest number of HIV infected individuals in the world. Developing and implementing effective biomedical interventions still remains urgent. Poor adherence has been commonly identified as one of the major barriers for the success of HIV prevention trials. A better understanding of how to improve adherence remains a research priority. In this analysis, younger age (<35 years), number of children ≤2, being single/not cohabiting and having a new partner during the study follow up were all significantly associated with poor adherence and subsequent HIV seroconversions. At population level, these three factors collectively associated with 56 % of the low level adherence and 75 % of the HIV seroconversions. Results highlighted the importance of effective adherence and comprehensive contraceptive counselling of women who enrol in HIV prevention trials. Culturally and socially appropriate methods are needed to achieve and maintain optimum adherence levels in future HIV prevention research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wand</LastName><ForeName>Handan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia. hwand@kirby.unsw.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramjee</LastName><ForeName>Gita</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>HIV Prevention Research Unit, Medical Research Council, Durban, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AIDS Behav</MedlineTA><NlmUniqueID>9712133</NlmUniqueID><ISSNLinking>1090-7165</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adherence</Keyword><Keyword MajorTopicYN="N">Carraguard</Keyword><Keyword MajorTopicYN="N">HIV seroconversions</Keyword><Keyword MajorTopicYN="N">South Africa</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27406228</ArticleId><ArticleId IdType="doi">10.1007/s10461-016-1471-1</ArticleId><ArticleId IdType="pii">10.1007/s10461-016-1471-1</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Afrique du Sud</li><li>Australie</li></country><region><li>Nouvelle-Galles du Sud</li></region><settlement><li>Sydney</li></settlement></list><tree><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Wand, Handan" sort="Wand, Handan" uniqKey="Wand H" first="Handan" last="Wand">Handan Wand</name></region></country><country name="Afrique du Sud"><noRegion><name sortKey="Ramjee, Gita" sort="Ramjee, Gita" uniqKey="Ramjee G" first="Gita" last="Ramjee">Gita Ramjee</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003888 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003888 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:27406228
|texte= Identifying Factors Associated with Low-Adherence and Subsequent HIV Seroconversions Among South African Women Enrolled in a Biomedical Intervention Trial.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:27406228" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |